Editas Medicine, Inc. Common Stock (EDIT) is a publicly traded Healthcare sector company. As of May 20, 2026, EDIT trades at $2.61 with a market cap of $247.70M and a P/E ratio of -2.19. EDIT moved +6.10% today. Year to date, EDIT is +20.00%; over the trailing twelve months it is +65.10%. Its 52-week range spans $0.91 to $4.54. Analyst consensus is buy with an average price target of $6.60. Rallies surfaces EDIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Editas Medicine, Inc. Common Stock (EDIT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. EDIT moved +6.10% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.61 |
| Market Cap | $247.70M |
| P/E Ratio | -2.19 |
| EPS | $-1.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.54 |
| 52-Week Low | $0.91 |
| Volume | 1.21M |
| Avg Volume | 0 |
| Revenue (TTM) | $38.69M |
| Net Income | $-108.95M |
| Gross Margin | 0.00% |
10 analysts cover EDIT: 0 strong buy, 5 buy, 3 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.60.